Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions
View ORCID ProfileJack Wilkinson, Calvin Heal, George A. Antoniou, Zarko Alfirevic, Alison Avenell, Virginia Barbour, Nicholas J L Brown, John Carlisle, Patrick Dicker, Jo Dumville, Andrew Grey, Lyle C Gurrin, Jill A Hayden, James Heathers, Kylie E Hunter, Toby Lasserson, Emily Lam, Sarah Lensen, Tianjing Li, Wentao Li, Elizabeth Loder, Andreas Lundh, Gideon Meyerowitz-Katz, Ben W Mol, Neil E O’ Connell, Lisa Parker, Barbara K. Redman, Anna Lene Seidler, Kyle A Sheldrick, Emma Sydenham, David J Torgerson, Madelon van Wely, Rui Wang, Lisa Bero, View ORCID ProfileJamie J Kirkham
doi: https://doi.org/10.1101/2023.09.21.23295626
Jack Wilkinson
1Centre for Biostatistics, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
Calvin Heal
1Centre for Biostatistics, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
George A. Antoniou
2Manchester Vascular Centre, Manchester University NHS Foundation Trust, Manchester, UK
3Division of Cardiovascular Sciences, School of Medical Sciences, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK
Zarko Alfirevic
4Emeritus Professor, University of Liverpool, UK
Alison Avenell
5Health Services Research Unit, University of Aberdeen, UK
Virginia Barbour
6Medical Journal of Australia, Sydney, Australia
Nicholas J L Brown
7Department of Psychology, Linnaeus University, Växjö, Sweden
John Carlisle
8Perioperative Medicine, Torbay hospital, UK
Patrick Dicker
9Department of Epidemiology and Public Health, Royal College of Surgeons in Ireland
Jo Dumville
10Division of Nursing, Midwifery & Social Work, School of Health Sciences, The University of Manchester, Manchester, UK
11NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
Andrew Grey
12Department of Medicine, University of Auckland, Auckland, New Zealand
Lyle C Gurrin
13School of Population and Global Health, The University of Melbourne, Australia
Jill A Hayden
14Department of Community Health & Epidemiology, Faculty of Medicine, Dalhousie University, Canada
James Heathers
15SafeBeat Rx Inc, USA
Kylie E Hunter
16Evidence Integration, NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia
Toby Lasserson
17Evidence Production and Methods Directorate, Cochrane Central Executive, London, UK
Emily Lam
18Independent lay member, unaffiliated, Cheshire, UK
Sarah Lensen
19Department of Obstetrics and Gynaecology, Royal Women’s Hospital, University of Melbourne, Melbourne, Australia
Tianjing Li
20Department of Ophthalmology, University of Colorado Anschutz Medical Campus
Wentao Li
21Department of Obstetrics and Gynaecology, Monash University, VIC, Australia
Elizabeth Loder
22The BMJ, London, UK
23Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA
Andreas Lundh
24Cochrane Denmark & Centre for Evidence-Based Medicine Odense, Department of Clinical Research, University of Southern Denmark, Denmark
25Department of Respiratory Medicine and Infectious Diseases, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark
Gideon Meyerowitz-Katz
26School of Health and Society, University of Wollongong, Wollongong, Australia
Ben W Mol
27Monash University, Clayton, Victoria, Australia
28Aberdeen Centre for Women’s Health Research, University of Aberdeen, Aberdeen, UK
Neil E O’ Connell
29Centre for Health and Wellbeing across the Lifecourse, Dept of Health Sciencess, Brunel University London, UK
Lisa Parker
30School of Pharmacy, Charles Perkins Centre, The University of Sydney, Australia
Barbara K. Redman
31Division of Medical Ethics, New York University Grossman School of Medicine, New York, NY
Anna Lene Seidler
16Evidence Integration, NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia
Kyle A Sheldrick
32Faculty of Medicine, University of New South Wales, Australia
Emma Sydenham
33Cochrane Central Production Service, UK
David J Torgerson
34York Trials Unit, Dept of Health Sciences, University of York, UK
Madelon van Wely
35Cochrane Gynaecology and Fertility Satellite and Cochrane Sexually Transmitted Infection Group, Amsterdam
36Reproduction and Development Research Institute, Amsterdam University Medical Center, The Netherlands
Rui Wang
21Department of Obstetrics and Gynaecology, Monash University, VIC, Australia
Lisa Bero
37University of Colorado Anschutz Medical Campus, Colorado, USA
Jamie J Kirkham
1Centre for Biostatistics, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
Data Availability
This is a research protocol. Datasets arising from the project will be made freely available.
Posted September 25, 2023.
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions
Jack Wilkinson, Calvin Heal, George A. Antoniou, Zarko Alfirevic, Alison Avenell, Virginia Barbour, Nicholas J L Brown, John Carlisle, Patrick Dicker, Jo Dumville, Andrew Grey, Lyle C Gurrin, Jill A Hayden, James Heathers, Kylie E Hunter, Toby Lasserson, Emily Lam, Sarah Lensen, Tianjing Li, Wentao Li, Elizabeth Loder, Andreas Lundh, Gideon Meyerowitz-Katz, Ben W Mol, Neil E O’ Connell, Lisa Parker, Barbara K. Redman, Anna Lene Seidler, Kyle A Sheldrick, Emma Sydenham, David J Torgerson, Madelon van Wely, Rui Wang, Lisa Bero, Jamie J Kirkham
medRxiv 2023.09.21.23295626; doi: https://doi.org/10.1101/2023.09.21.23295626
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions
Jack Wilkinson, Calvin Heal, George A. Antoniou, Zarko Alfirevic, Alison Avenell, Virginia Barbour, Nicholas J L Brown, John Carlisle, Patrick Dicker, Jo Dumville, Andrew Grey, Lyle C Gurrin, Jill A Hayden, James Heathers, Kylie E Hunter, Toby Lasserson, Emily Lam, Sarah Lensen, Tianjing Li, Wentao Li, Elizabeth Loder, Andreas Lundh, Gideon Meyerowitz-Katz, Ben W Mol, Neil E O’ Connell, Lisa Parker, Barbara K. Redman, Anna Lene Seidler, Kyle A Sheldrick, Emma Sydenham, David J Torgerson, Madelon van Wely, Rui Wang, Lisa Bero, Jamie J Kirkham
medRxiv 2023.09.21.23295626; doi: https://doi.org/10.1101/2023.09.21.23295626
Subject Area
Subject Areas
- Addiction Medicine (410)
- Allergy and Immunology (723)
- Anesthesia (214)
- Cardiovascular Medicine (3072)
- Dermatology (260)
- Emergency Medicine (461)
- Epidemiology (13003)
- Forensic Medicine (13)
- Gastroenterology (858)
- Genetic and Genomic Medicine (4813)
- Geriatric Medicine (444)
- Health Economics (749)
- Health Informatics (3044)
- Health Policy (1100)
- Hematology (406)
- HIV/AIDS (954)
- Medical Education (453)
- Medical Ethics (119)
- Nephrology (498)
- Neurology (4588)
- Nursing (244)
- Nutrition (680)
- Oncology (2378)
- Ophthalmology (672)
- Orthopedics (267)
- Otolaryngology (333)
- Pain Medicine (300)
- Palliative Medicine (87)
- Pathology (514)
- Pediatrics (1235)
- Primary Care Research (517)
- Public and Global Health (7166)
- Radiology and Imaging (1596)
- Respiratory Medicine (942)
- Rheumatology (458)
- Sports Medicine (400)
- Surgery (508)
- Toxicology (65)
- Transplantation (219)
- Urology (188)